{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:42:31Z","timestamp":1786977751139,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"MHCR for conceptual development of research organization","award":["RVO-VFN64165\/2012"],"award-info":[{"award-number":["RVO-VFN64165\/2012"]}]},{"name":"MHCR for conceptual development of research organization","award":["NT\/13899 MZCR"],"award-info":[{"award-number":["NT\/13899 MZCR"]}]},{"name":"MHCR for conceptual development of research organization","award":["COST-EuGESMA"],"award-info":[{"award-number":["COST-EuGESMA"]}]},{"name":"MHCR for conceptual development of research organization","award":["PRVOUK-P27\/LF1"],"award-info":[{"award-number":["PRVOUK-P27\/LF1"]}]},{"name":"MHCR for conceptual development of research organization","award":["GACR-P302\/12\/G157\/1"],"award-info":[{"award-number":["GACR-P302\/12\/G157\/1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Chromosomes &amp;amp; Cancer"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>\n                    Chromosome 11 abnormalities are found in many hematological malignancies. In acute myeloid leukemia (AML), a proto\u2010oncogene\n                    <jats:italic>MLL<\/jats:italic>\n                    (11q23.3) is frequently altered. However, rearrangements involving other regions of chromosome 11 have been reported. Therefore, we have characterized the chromosome 11 breakpoints and common deleted and amplified areas in the bone marrow or peripheral blood cells of newly diagnosed patients with AML. Using molecular\u2013cytogenetic methods (multicolor fluorescence in situ hybridization (mFISH), multicolor banding (mBAND), microarrays, and FISH with bacterial artificial chromosome (BAC) probes, chromosome 11 abnormalities were delineated in 54 out of 300 (18%) newly diagnosed AML patients. At least 36 different chromosome 11 breakpoints were identified; two were recurrent (11p15.4 in the\n                    <jats:italic>NUP98<\/jats:italic>\n                    gene and 11q23.3 in the\n                    <jats:italic>MLL<\/jats:italic>\n                    gene), and three were possibly nonrandom: 11p13 (ch11:29.31\u201031.80 Mb), 11p12 (ch11:36.75\u201037.49 Mb) and 11q13.2 (68.31\u201068.52 Mb). One new\n                    <jats:italic>MLL<\/jats:italic>\n                    gene rearrangement is also described. No commonly deleted region of chromosome 11 was identified. However, some regions were affected more often: 11pter\u201011p15.5 (\n                    <jats:italic>n<\/jats:italic>\n                    = 4; ch11:0\u20103.52 Mb), 11p14.1\u201011p13 (\n                    <jats:italic>n<\/jats:italic>\n                    = 4; ch11:28.00\u201031.00 Mb) and 11p13 (\n                    <jats:italic>n<\/jats:italic>\n                    = 4; ch11:31.00\u201031.50 Mb). One commonly duplicated (3 copies) region was identified in chromosomal band 11q23.3\u201011q24 (\n                    <jats:italic>n<\/jats:italic>\n                    = 9; ch11:118.35\u2010125.00 Mb). In all eight cases of 11q amplification (&gt;3 copies), only the 5\u2032 part of the\n                    <jats:italic>MLL<\/jats:italic>\n                    gene was affected. This study highlights several chromosome 11 loci that might be important for the leukemogeneic process in AML. \u00a9 2013 Wiley Periodicals ,Inc.\n                  <\/jats:p>","DOI":"10.1002\/gcc.22058","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T23:05:47Z","timestamp":1444691147000},"page":"619-635","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia"],"prefix":"10.1002","volume":"52","author":[{"given":"Iveta","family":"Sarova","sequence":"first","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"},{"name":"Center of Oncocytogenetics Institute of Medical Biochemistry and Laboratory Diagnostics General Faculty Hospital and 1<sup>st<\/sup> Faculty of Medicine of Charles University Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Brezinova","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Zemanova","sequence":"additional","affiliation":[{"name":"Center of Oncocytogenetics Institute of Medical Biochemistry and Laboratory Diagnostics General Faculty Hospital and 1<sup>st<\/sup> Faculty of Medicine of Charles University Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Bystricka","sequence":"additional","affiliation":[{"name":"Center of Oncocytogenetics Institute of Medical Biochemistry and Laboratory Diagnostics General Faculty Hospital and 1<sup>st<\/sup> Faculty of Medicine of Charles University Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Krejcik","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Soukup","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vydra","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Cermak","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jonasova","sequence":"additional","affiliation":[{"name":"1<sup>st<\/sup> Faculty of Medicine Charles University in Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Michalova","sequence":"additional","affiliation":[{"name":"Cytogenetic Department Institute of Hematology and Blood Transfusion Prague Czech Republic"},{"name":"Center of Oncocytogenetics Institute of Medical Biochemistry and Laboratory Diagnostics General Faculty Hospital and 1<sup>st<\/sup> Faculty of Medicine of Charles University Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1931","article-title":"The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia","volume":"25","author":"Braekeleer M","year":"2005","journal-title":"Anticancer Res"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(03)00032-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2010.02.011"},{"key":"e_1_2_6_5_1","first-page":"329471","article-title":"Using bacterial artificial chromosomes in leukemia research: The experience at the university cytogenetics laboratory in Brest, France","author":"Braekeleer E","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1312"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2007.04.005"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-346643"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1264"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03006927"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2010.01415.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.040569197"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2009.04.015"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.11.022"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.11.006"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404150"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.33"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.04.007"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)00040-7"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-001149"},{"key":"e_1_2_6_21_1","first-page":"746","article-title":"Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization","volume":"90","author":"Nebral K","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20467"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2010.08.007"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2008.07.012"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2163"},{"key":"e_1_2_6_26_1","first-page":"223","article-title":"The galanin system in cancer","volume":"102","author":"Rauch I","year":"2010","journal-title":"EXS"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5450"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cancergencyto.2009.05.008","article-title":"A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia","volume":"195","author":"\u0160\u00e1rov\u00e1 I","year":"2006","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2010.02.012"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.07.022"},{"key":"e_1_2_6_31_1","volume-title":"ISCN: An International System for Human Cytogenetic Nomenclature","author":"Shaffer LG","year":"2009"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2010.01.008"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20658"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2007.06.012"}],"container-title":["Genes, Chromosomes and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgcc.22058","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gcc.22058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T19:36:26Z","timestamp":1700595386000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.22058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/gcc.22058"],"URL":"https:\/\/doi.org\/10.1002\/gcc.22058","archive":["Portico"],"relation":{},"ISSN":["1045-2257","1098-2264"],"issn-type":[{"value":"1045-2257","type":"print"},{"value":"1098-2264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]}}}